I Singh - All India Inst Med Sci, New Delhi, India

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 294 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Population Pharmacokinetics of Sacituzumab Govitecan in Patients with Metastatic Triple-Negative Breast Cancer and Other Solid Tumors

Abhishek G. Sathe,Indrajeet Singh,Pratap Singh,Paul M. Diderichsen, Xiaohui Wang, Peter Chang, Atiya Taqui,See Phan,Sandhya Girish, Ahmed A. Othman

Clinical pharmacokineticsno. 5 (2024): 669-681

引用0浏览0WOS引用

Prevalence and prognosis of npm1, cebpa, andflt3 in cytogenetically- normal aml patients treated at a tertiary care center in north india

Aparna Ningombam,Deepak Verma,Rajive Kumar,Jay Singh,M. Shadab Ali, Avinash Kumar Pandey,Inder Singh,Sameer Bakshi,Atul Sharma,Deepam Pushpam,Jayanth Kumar Palanichamy,Pranay Tanwar,Amar Ranjan Singh,Anita Chopra

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2023): 129-129

引用0浏览0引用

Prognostic Relevance of NPM1, CEBPA, and FLT3 Mutations in Cytogenetically Normal Adult AML Patients

Aparna Ningombam,Deepak Verma,Rajive Kumar,Jay Singh,M Shadab Ali,Avanish Kumar Pandey,Inder Singh,Sameer Bakhshi,Atul Sharma,Deepam Pushpam,Jayanth Kumar Palanichamy,Pranay Tanwar,Amar Ranjan Singh,Anita Chopra

PubMed（2023）

引用0浏览0WOS引用

Prognostic Relevance of Surface Expression of Cytokine Receptor-Like Factor 2 in Pediatric B-lineage Acute Lymphoblastic Leukemia

Jay Singh,Mercilena Benjamin,Avanish Kumar Pandey,Sarita Kumari,Mohammad Shadab Ali,Jayanth Kumar Palanichamy,Sameer Bakhshi,Amitabh Singh,Deepam Pushpam,Akash Kumar,Rachna Seth,Inder Singh,Pranay Tanwar,Amar Ranjan Singh,Gunjan Sharma,Mohit Arora,Anita Chopra

PubMedno. 6 (2023): 2452-2470

引用0浏览0WOS引用

PROGNOSTIC RELEVANCE OF MN1 EXPRESSION IN CYTOGENETICALLY NORMAL ADULT AML PATIENTS

Anita Chopra,Aparna Ningombam,Deepak Verma,Rajive Kumar,Jay Singh,M. Shadab Ali,Avnish Pandey,Inder Singh,Sameer Bakhshi,Atul Sharma,Deepam Pushpam,Jayanth Palanichamy,Pranay Tanwar,Amar Singh

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY（2023）

引用0浏览0引用

PHARMACOKINETICS (PK) OF SACITUZUMAB GOVITECAN (SG), A TROP-2-DIRECTED ANTIBODY-TOPOISOMERASE I INHIBITOR SN-38 DRUG-CONJUGATE, IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS

I. Singh,A. Sathe,P. Singh, F. Boakye-Agyeman, L. Tatalick, T. Goswami,S. Girish,A. Othman

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022): S48-S48

引用0浏览0引用

Prognostic Utility of Key Copy Number Alterations in T Cell Acute Lymphoblastic Leukemia

Sarita Kumari,M. Shadab Ali,Jay Singh,Mohit Arora,Deepak Verma,Avanish Kumar Pandey,Mercilena Benjamin,Sameer Bakhshi,Jayanth Kumar Palanichamy,Atul Sharma,Inder Singh,Pranay Tanwar,Amar Ranjan Singh,Deepam Pushpam,Imteyaz Qamar,Anita Chopra

Hematological oncology（2022）

引用4浏览0WOS引用

EVALUATION OF THE SINGLE DOSE PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF GS-3583, A FLT3 AGONIST FC FUSION PROTEIN, IN A PHASE 1 STUDY IN HEALTHY VOLUNTEERS

A. Dauki, N. Rajakumaraswamy, T. Trowe,I. Singh, A. Vashishtha, W. Weng, M. Kuhne,A. Qin, C. Schwabe, A. Othman

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022): S18-S18

引用0浏览0引用

189P Pharmacokinetics (PK) of Sacituzumab Govitecan (SG) in Patients (pts) with Metastatic Triple-Negative Breast Cancer (mtnbc) and Other Solid Tumors

A. G. Sathe,I. Singh,P. Singh,P. Diderichsen, X. Wang, P. Chang,S-C. Phan,S. Girish, A. A. Othman

Annals of oncology (2022): S214-S214

引用1浏览0引用

IMPACT OF UDP-GLUCURONOSYL TRANSFERASE 1A1 (UGT1A1) POLYMORPHISMS ON THE PHARMACOKINETICS (PK) OF SACITUZUMAB GOVITECAN (SG)

A. Sathe,P. Singh,I. Singh, F. Boakye-Agyeman, T. Goswami,S. Girish, A. Othman

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022): S45-S45

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn